Literature DB >> 16360607

Drooling of saliva: a review of the etiology and management options.

Jean-Paul Meningaud1, Poramate Pitak-Arnnop, Luc Chikhani, Jacques-Charles Bertrand.   

Abstract

Drooling of saliva appears to be the consequence of a dysfunction in the coordination of the swallowing mechanism, resulting in excess pooling of saliva in the anterior portion of the oral cavity and the unintentional loss of saliva from the mouth. Drooling can produce significant negative effects on physical health and quality of life, especially in patients with chronic neurological disabilities. Various approaches to manage this condition have been described in the literature, including oral motor therapy, behavior modification via biofeedback, orofacial regulation therapy, drug therapy, radiotherapy, and surgical treatments. Minimally invasive modalities, such as injection of botulinum toxin, photocoagulation, and acupuncture, have also been reported. This article provides a comprehensive and thorough overview of drooling, with an emphasis on understanding its etiologies and modalities of treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16360607     DOI: 10.1016/j.tripleo.2005.08.018

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  27 in total

Review 1.  Evidence for the effectiveness of botulinum toxin for sialorrhoea.

Authors:  D D Truong; R Bhidayasiri
Journal:  J Neural Transm (Vienna)       Date:  2008-02-04       Impact factor: 3.575

2.  Anatomical localization of submandibular gland for botulinum toxin injection.

Authors:  J H Lee; B N Lee; S O Kwon; R H Chung; S H Han
Journal:  Surg Radiol Anat       Date:  2010-03-11       Impact factor: 1.246

Review 3.  Clinical features associated with drooling in Parkinson's disease.

Authors:  David Nascimento
Journal:  Neurol Sci       Date:  2021-01-14       Impact factor: 3.307

Review 4.  An update on the use of botulinum toxin therapy in Parkinson's disease.

Authors:  Reversa Mills; Laxman Bahroo; Fernando Pagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

5.  Management of drooling in disabled patients with scopolamine patches.

Authors:  Abigail Mato; Jacobo Limeres; Inmaculada Tomás; Maria Muñoz; Concepción Abuín; Javier F Feijoo; Pedro Diz
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

6.  Botulinum toxin in the treatment of drooling in tetraplegic patients with brain injury.

Authors:  Sung Hwa Ko; Yong Beom Shin; Ji Hong Min; Myung Jun Shin; Jae Hyeok Chang; Yong-Il Shin; Hyun-Yoon Ko
Journal:  Ann Rehabil Med       Date:  2013-12-23

7.  Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.

Authors:  João Costa; Maria Luz Rocha; Joaquim Ferreira; Teresinha Evangelista; Miguel Coelho; Mamede de Carvalho
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

8.  Endoscope-assisted submandibular sialadenectomy: a review of outcomes, complications, and ethical concerns.

Authors:  Poramate Pitak-Arnnop; Niels Christian Pausch; Kittipong Dhanuthai; Kraison Sappayatosok; Pichit Ngamwannagul; Ute Bauer; Robert Sader; Alexander D Rapidis; Christian Hervé; Alexander Hemprich
Journal:  Eplasty       Date:  2010-05-21

Review 9.  Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.

Authors:  Marcelo Merello
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  The association of drooling and health-related quality of life in children with cerebral palsy.

Authors:  Shih-Chung Chang; Chin-Kai Lin; Li-Chen Tung; Nai-Yin Chang
Journal:  Neuropsychiatr Dis Treat       Date:  2012-12-11       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.